Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present SELLAS Life Sciences Group, Inc. (NASDAQ: SLS).

Full DD Report for SLS

You must become a subscriber to view this report.


Recent News from (NASDAQ: SLS)

Big Biotech May Be After These Technologies
HENDERSON, NV / ACCESSWIRE / November 6, 2018 / Big biotech stock buybacks "have destroyed more than $12 billion in value, and generated no positive return in total, at least as a portfolio investment," Leerink analyst Geoffry Porges recently said in a Marketwatch report. Big biotech has sp...
Source: ACCESSWIRE IA
Date: November, 06 2018 10:30
Key events next week - healthcare
Noteworthy events during the week of November 4 - 10 for healthcare investors. More news on: Dare Bioscience, Inc., EyePoint Pharmaceuticals, Inc., Aduro Biotech, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 02 2018 10:12
SBUX, SLS, EXEL among premarket's big gainers
Pacific Biosciences of California (NASDAQ: PACB ) +68%  on Q3 result . More news on: Pacific Biosciences of California, China Internet Nationwide Financial Services Inc., Exelixis, Inc., Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 02 2018 09:18
Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and SELLAS Life Sciences
NEW YORK, NY / ACCESSWIRE / November 2, 2018 / Teva shares were skyrocketing on a third quarter financial report that beat analysts’ estimates and a raised outlook. Shares of Sellas Life Sciences were also seeing gains despite any news from the company. The 36% gain for Sellas...
Source: ACCESSWIRE IA
Date: November, 02 2018 08:00
Fitbit, Clovis Oncology and FreightCar America among midday movers (11.01.2018)
More news on: SELLAS Life Sciences Group, Inc., Globus Maritime Ltd., FormFactor, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: November, 01 2018 12:39
3 Biotechnology & Healthcare Stocks To Watch On Thursday
CORAL GABLES, FL / ACCESSWIRE / November 1, 2018 / The healthcare sector is often regarded as a hedge from regular market forces. Recent volatility has brought this particular topic to light ahead of US midterm elections . Care in the form of providers, equipment, medicine, technology and...
Source: ACCESSWIRE IA
Date: November, 01 2018 10:05
BT, NXPI among top gainers
SELLAS Life Sciences (NASDAQ: SLS ) +20%  on positive analyst action . More news on: SELLAS Life Sciences Group, Inc., Attunity Ltd, Floor & Decor Holdings, Inc., Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 01 2018 09:27
Premarket Gainers as of 9:15 am (9/13/2018)
PI   +39%  on Q2 earnings . More news on: Impinj, Inc., Geron Corporation, GNC Holdings, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 13 2018 09:27
SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency for Galinpepimut-S for the Treatment of Patients with Multiple Myeloma
NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, ...
Source: GlobeNewswire
Date: September, 13 2018 08:30
SELLAS Life Sciences down 5% on Q2 results
SELLAS Life Sciences ( SLS ) Q2 results : Revenues: $0; Net Loss: ($8.5M) (-44.1%); Loss Per Share: ($1.26) (+72.0%); Quick Assets: $1.3M (-43.5%). More news on: SELLAS Life Sciences Group, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ......
Source: SeekingAlpha
Date: August, 15 2018 09:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-141.221.151.231.14463,758

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1141,40788,34846.8681Short
2018-12-1029,02254,38553.3640Short
2018-12-0732,99184,34839.1130Short
2018-12-0690,407172,54752.3956Short
2018-12-04102,560152,05067.4515Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SLS.


About SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)

Logo for SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)

Not available

 

Contact Information

 

 

Current Management

  • Mark W Schwartz / President, CEO
  • Gene Mack / CFO, Treasurer
    • Effective April , , the Registrant appointed Gene Mack, age , as Chief Financial Officer and Treasurer of the Registrant. From June until April , Mr. Mack served as a consultant to Nicox S.A. and Ascendia Pharmaceuticals, providing chief financial officer, business development and strategic advising services. From December to April , Mr. Mack was Senior Director, Business Development and Corporate Finance, at Edge Therapeutics, Inc. From to , Mr. Mack was a senior biotech analyst at a number of different institutions including Lazard, HSBC and Gruntal amp Co.
  • Thomas J. Knapp / General Counsel
  • Margaret Kivinski / Consultant
  • Irving M. Einhorn /
  • Stephen S. Galliker /
  • Mark W Schwartz /

Current Share Structure

  • Market Cap: $36,674,784 - 05/18/2018
  • Issue and Outstanding: 6,572,542 - 04/06/2018

 


Recent Filings from (NASDAQ: SLS)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 06 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: July, 26 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: July, 26 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: July, 26 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: July, 23 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: July, 23 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: July, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 23 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: July, 19 2018

 

 


Daily Technical Chart for (NASDAQ: SLS)

Daily Technical Chart for (NASDAQ: SLS)


Stay tuned for daily updates and more on (NASDAQ: SLS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: SLS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SLS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SLS and does not buy, sell, or trade any shares of SLS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/